Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HR | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | CCNYL1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | MRPL9 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | KSR2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | LSM14A | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | ETF1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
mRNA | TERF1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
mRNA | SEPT10 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
mRNA | PCDHAC1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | LRRC34 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |